首页> 外文OA文献 >Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients

【2h】

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients

机译：解释麦考酚酸暴露的变异性以优化麦考酚酸酯的剂量：肾移植受者中麦考酚酸的群体药代动力学荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
van Hest, Reinier M.; Mathot, Ron A. A.; Pescovitz, Mark D.; Gordon, Robert; Mamelok, Richard D.; van Gelder, Teun;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 20:13:33

相似文献

外文文献
中文文献
专利

1. Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil Dosing: A Population Pharmacokinetic Meta-Analysis of Mycophenolic Acid in Renal Transplant Recipients [J] . Mark D. Pescovitz, Reinier M. van Hest, Richard D. Mamelok, Journal of the American Society of Nephrology: JASN . 2006,第3期

机译：解释麦考酚酸暴露的变异性以优化麦考酚酯Mofetil剂量：肾移植受者中麦考酚酸的群体药代动力学Meta分析
2. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. [J] . van Hest RM, Mathot RA, Pescovitz MD, Journal of the American Society of Nephrology: JASN . 2006,第3期

机译：解释麦考酚酸暴露的变异性以优化麦考酚酸酯的剂量：对肾移植接受者中麦考酚酸的人群药代动力学荟萃分析。
3. Population Pharmacokinetics of Mycophenolic Acid : A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients. [J] . de-Winter BC, van-Gelder T, Glander P, Clinical pharmacokinetics . 2008,第12期

机译：麦考酚酸的群体药代动力学：肾脏移植接受者的肠溶麦考酚酸钠和麦考酚酯之间的比较。
4. Overcoming Challenges in Developing a Rugged LC-MS/MS Method for Mycophenolate Mofetil and Mycophenolic Acid in Human Plasma [C] . Nick Peng, Iffat Balkhi, Anita Towers, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：在人血浆中克服霉菌MoFetil和霉酚酸的粗糙LC-MS / MS方法克服挑战
5. The pharmacokinetics and pharmacodynamics of mycophenolic acid in kidney transplant recipients. [D] . Patel, Chirag G. 2006

机译：麦考酚酸在肾移植受者中的药代动力学和药效学。
6. Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil [O] . Dr. H Li, Dr. D E Mager, Dr. B M Sandmaier, -1

机译：HCT接受物中霉霉酸的人口药代动力学和剂量优化接受口服霉酚酸酯的MoFetil
7. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. [O] . L T Weber, M Shipkova, T Lamersdorf, 1998

机译：霉菌酸（MPA）的药代动力学和小儿和成人肾移植受者MPA自由分数的决定因素。德国研究组在儿科肾移植受体中的霉菌霉素治疗。

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients

著录项

相似文献

相关主题

期刊订阅